
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark holds a strong position in the tissue and hygiene market, with the majority of its sales derived from personal care products and consumer tissue, showcasing its brand strength with well-known names like Huggies and Kleenex. The company plans to enhance its innovation pipeline significantly in 2026, leveraging new technology to improve product offerings and maintain competitiveness. Additionally, with more than half of its sales generated in North America and significant international presence, the anticipated integration of Kenvue's consumer health portfolio in 2026 is likely to bolster its market share and revenue potential.
Bears say
Kimberly-Clark is facing a challenging financial outlook, as indicated by a significant adjustment in its forecast, with a -4.0% estimate for North America organic sales decline in the third quarter of 2025, down from a previous estimate of +4.5%. Additionally, the firm has reported a -2.7% decline in US measured retail sales for the third quarter of 2025 year-to-date, reflecting ongoing weakness in demand. Furthermore, earnings per share (EPS) projections have been lowered, with estimates for fiscal year 2025 adjusted from $7.60 to $7.41 and for 2026 reduced from $8.00 to $7.85.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares